Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CERS
CERS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CERS News
Cerus (CERS) Q4 2025 Earnings Call Transcript
Mar 02 2026
NASDAQ.COM
Cerus Reports Q4 2025 Financial Results with Revenue Growth
Mar 02 2026
seekingalpha
Cerus Scheduled to Announce Q4 Earnings on March 2nd
Mar 01 2026
seekingalpha
Cerus Corporation to Present at TD Cowen Health Care Conference
Feb 20 2026
Businesswire
Cerus Corporation to Present at TD Cowen Health Care Conference
Feb 20 2026
Newsfilter
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
Jan 14 2026
Benzinga
China SXT Pharmaceuticals (SXTC) Closes $10 Million Offering, Stock Rises 17.4%
Jan 14 2026
NASDAQ.COM
Cerus (CERS) Q4 Product Revenue Expected at $57.8M, 14% YoY Growth
Jan 12 2026
seekingalpha
Cerus Reports 14% Increase in 2025 Product Revenue to $206.1 Million
Jan 11 2026
Businesswire
Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying
Dec 11 2025
NASDAQ.COM
Cerus Corporation Unveils Abstracts and Hosts Industry Workshop on IFC at the 2025 AABB Annual Meeting
Oct 21 2025
Newsfilter
Daily Upgrade Report for Validea's James P. O'Shaughnessy Strategy - September 20, 2025
Sep 21 2025
NASDAQ.COM
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
Jul 21 2025
Newsfilter
Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/3/2025
Jul 03 2025
NASDAQ.COM
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
Jul 02 2025
Newsfilter
Cerus Corporation Celebrates World Blood Donor Day 2025
Jun 13 2025
Newsfilter
Show More News
